DOLPHIN MEDICAL SERVICES LTD.

Rarever Financial Advisors, acting as the Manager to the Offer, announced a Detailed Public Statement on behalf of Mr. Amarandhar Reddy Kotha and Mr. Mallour Rajesh Kumar (the Acquirers) for an open offer to acquire up to 39,25,988 equity shares of Dolphin Medical Services Limited, constituting 26% of the total paid-up equity shares. The offer price is ₹4.80 per equity share, payable in cash. This open offer complies with Regulation 4 of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Rarever Financial Advisors, acting as the manager, announced an open offer on behalf of Mr. Amarandhar Reddy Kotha and Mr. Mallour Rajesh Kumar to acquire up to 39,25,988 equity shares of Dolphin Medical Services Ltd, constituting 26% of the company's total paid-up equity. The offer price is ₹4.80 per share, payable in cash. This open offer complies with SEBI's Substantial Acquisition of Shares and Takeovers Regulations.

Dolphin Medical Services Ltd declared its audited financial results for the fourth quarter and year ended March 31, 2026. Key financial figures include a total revenue of ₹78.69 lakhs for FY26 and a net profit of ₹4.19 lakhs. The results were reviewed by the Audit Committee and approved by the Board of Directors on May 16, 2026. The company's earnings per share stood at ₹0.02 for continuing operations.

Dolphin Medical Services Ltd declared its audited financial results for the fourth quarter and year ended March 31, 2026. The Board of Directors approved the results on May 16, 2026. Revenue from operations for FY26 stood at ₹75.01 lakhs, with a net profit of ₹4.19 lakhs. The company's earnings per share (EPS) for continuing operations was ₹0.02. Total expenses for the year were ₹72.57 lakhs. The board meeting commenced at 6:00 P.M. and concluded at 7:00 P.M.

Rarever Financial Advisors announced an open offer on behalf of Mr. Amarandhar Reddy Kotha and Mr. Mallour Rajesh Kumar to acquire 39,25,988 equity shares of Dolphin Medical Services Ltd, representing 26% of the total paid-up equity, at a price of ₹4.80 per share. This offer complies with SEBI regulations and aims to acquire control of the Target Company.

Dolphin Medical Services Ltd has scheduled a Board of Directors meeting on May 16, 2026, to consider and approve the audited financial results for the fourth quarter and financial year ended March 31, 2026. The meeting will be held at the company's registered office in Telangana.

Dolphin Medical Services Ltd. announced the outcome of its Board Meeting held on April 22, 2026. The Board approved the appointment of Mr. KOLACHALAMA SAIKUMAR and Smt. SRUJANA SIDDHANI as Independent Directors for a period of five years each. Concurrently, the company noted the resignations of Mr. NARENDRA SEENAKARKERA and Mr. VINAY VISHNURAJNAYAK as Independent Directors, and Mr. BUDDHA SAGAR NANAPANENI as a Director, all with immediate effect. The new appointments aim to strengthen the board's expertise with backgrounds in finance and healthcare.

Dolphin Medical Services Ltd. announced the outcome of its Board meeting held on April 22, 2026. The Board approved the appointment of Mr. Kolachalama Saikumar (DIN: 11660879) and Smt. Srujana Siddhani (DIN: 10221292) as Independent Directors for a period of 5 years. Concurrently, Mr. Narendra Seenakarkera (DIN: 01916929), Mr. Vinay Vishnurajnayak (DIN: 01979345), and Mr. Buddha Sagar Nanapaneni (DIN: 08005028) resigned as Directors from the company with immediate effect. The Board placed on record its appreciation for their contributions during their tenure.

Dolphin Medical Services Ltd has announced a Board of Directors meeting scheduled for April 22, 2026. The primary agenda items include the consideration and approval of board meeting intimations. Key discussions will revolve around the appointment of Mr. KOLACHALAMA SAIKUMAR and Smt. SRUJANA SIDDHANI as Independent Directors, and the resignation of Mr. NARENDRA SEENAKARKERA, Mr. VINAY VISHNURAJNAYAK, and Mr. BUDDHA SAGARNANAPANENI as Directors. The meeting will also address the reconstitution of board committees following these changes.

Dolphin Medical Services Ltd announced a corrigendum to the outcome of the Board Meeting held on 12th February, 2026. The corrigendum records the resignation of the Chief Financial Officer (CFO), Mrs. Lakshmi Sudha Madala, which was inadvertently omitted in the original Board Meeting outcome. Mrs. Madala tendered her resignation due to personal reasons, which was accepted by the Board. The Board has acknowledged and accepted her resignation, placing on record its appreciation for the services rendered during her tenure.